Dr. Lluis Arias

Dr. Lluis Arias is a specialized medical practice and clinical research entity based in Barcelona, Spain, led by the prominent ophthalmologist Dr. Lluís Arias Barquet. The organization functions as a key clinical trial site for major global pharmaceutical companies, specializing in the study and treatment of vitreoretinal diseases. Dr. Arias is a recognized Key Opinion Leader (KOL) in the field of retina, participating in Phase 2 and Phase 3 trials for innovative therapies such as anti-VEGF agents. The practice is integrated into the broader Spanish ophthalmic research ecosystem, collaborating with institutions like the Bellvitge University Hospital and the Institut de Microcirurgia Ocular (IMO). Through these collaborations, the entity contributes to the development of novel treatments for conditions like age-related macular degeneration and diabetic retinopathy.